Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.
Open Access
- 1 April 1985
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 75 (4) , 1124-1130
- https://doi.org/10.1172/jci111806
Abstract
Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome. Each patient exhibited a deficiency of plasma free carnitine (mean 11.7 +/- 4.0 [SD] nmol/ml) compared with normal control values (42.0 +/- 9.0 nmol/ml) (P less than 0.001). Mean plasma acyl carnitine in the cystinotic subjects was normal. Four subjects with Fanconi syndrome but not cystinosis displayed the same abnormal pattern of plasma carnitine levels; controls with acidosis or a lysosomal storage disorder (Fabry disease), but not Fanconi syndrome, had entirely normal plasma carnitine levels. Two postrenal transplant subjects with cystinosis but without Fanconi syndrome also had normal plasma carnitine levels. Absolute amounts of urinary free carnitine were elevated in cystinotic individuals with Fanconi syndrome. In all 21 subjects with several different etiologies for the Fanconi syndrome, the mean fractional excretion of free carnitine (33%) as well as acyl carnitine (26%) greatly exceeded normal values (3 and 5%, respectively). Total free carnitine excretion in Fanconi syndrome patients correlated with total amino acid excretion (r = 0.76). Two cystinotic patients fasted for 24 h and one idiopathic Fanconi syndrome patient fasted for 5 h showed normal increases in plasma beta-hydroxybutyrate and acetoacetate, which suggested that hepatic fatty acid oxidation was intact despite very low plasma free carnitine levels. Muscle biopsies from two cystinotic subjects with Fanconi syndrome and plasma carnitine deficiency had 8.5 and 13.1 nmol free carnitine per milligram of noncollagen protein, respectively (normal controls, 22.3 and 17.1); total carnitines were 11.8 and 13.3 nmol/mg noncollagen protein (controls 33.5, 20.0). One biopsy revealed a mild increase in lipid droplets. The other showed mild myopathic features with variation in muscle fiber size, small vacuoles, and an increase in lipid droplets. In renal Fanconi syndrome, failure to reabsorb free and acyl carnitine results in a secondary plasma and muscle free carnitine deficiency.This publication has 34 references indexed in Scilit:
- Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.Journal of Clinical Investigation, 1984
- Carnitine deficiency in premature infants receivingtotal parenteral nutrition: Effect of l-carnitine supplementationThe Journal of Pediatrics, 1983
- Pantethine depletes cystinotic fibroblasts of cystineThe Journal of Pediatrics, 1983
- Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transportThe Journal of Pediatrics, 1982
- Cystine Transport Is Defective in Isolated Leukocyte Lysosomes from Patients with CystinosisScience, 1982
- Systemic Carnitine Deficiency Presenting as Familial Endocardial FibroelastosisNew England Journal of Medicine, 1981
- Systemic carnitine deficiencyThe Journal of Pediatrics, 1978
- CARNITINE DEFICIENCY INDUCED DURING INTERMITTENT HÆMODIALYSIS FOR RENAL FAILUREThe Lancet, 1978
- 5-Oxoprolinuria: Biochemical observations and case reportThe Journal of Pediatrics, 1977
- Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.Journal of Clinical Investigation, 1976